gip vs glp 1 Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art Dual GLP-1/GIP Agonist | Tirzepatide
Description
I was a little hesitant to try these patches at first because I didnt think that they would work

Abstract Aim Obesity is a global epidemic

In the Phase 2a obesity study, GSBR-1290 demonstrated clinically meaningful and statistically significant weight loss

Weight loss was more pronounced in patients with a BMI over 35, compared to those under 35

injection it is absorbed over 1-3 days with a steady state plasma level being achieved after 4-5 weeks of weekly dosing
While effective, they come with notable side effects, including nausea, digestive issues and some serious issues : Vision Impairment Alert Semaglutide, a widely used GLP-1 receptor agonist, has been linked to a significantly higher rate of reported vision problems